www.nationalcprassociation.com

Członkowie Konsorcjum BBMRI.pl opracowali plany budowy Narodowej Sieci Biobanków w Polsce. Założenia projektu opublikowano na łamach Biopreservation and Biobanking (IF=1,804). Zapraszamy do lektury.

"Organization of BBMRI.pl: The Polish Biobanking Network"

 

Małgorzata Witoń,1 Dominik Strapagiel,2 Joanna Gleńska-Olender,1 Anna Chróścicka,3 Katarzyna Ferdyn,4 Jarosław Skokowski,5,6 Leszek Kalinowski,5 Jakub Pawlikowski,7 Błażej Marciniak,2 Markus Pasterk,8 Agnieszka Matera-Witkiewicz,9 and Łukasz Kozera10
1Regional Science and Technology Center, Swietokrzyski Biobank, Checiny, Poland.
2Biobank Lab, Department of Molecular Biophysics, University of Lodz, Lodz, Poland.
3Department of Histology and Embryology, Center for Biostructure Research, Center for Preclinical Research and Technology, Medical University of Warsaw, Warsaw, Poland.
4BMCT BioMed Consulting & Training, Warsaw, Poland.
5Department of Medical Laboratory Diagnostics and Bank of Frozen Tissues & Genetic Specimens, Medical University of Gdansk, Gdansk, Poland.
6Department of Surgical Oncology, Medical University of Gdansk, Gdansk, Poland.
7Department of Ethics and Human Philosophy, Medical University of Lublin, Lublin, Poland.
8BBMRI-ERIC, Graz, Austria.
9Screening Laboratory of Biological Activity Test and Collection of Biological Material, Wroclaw Medical University, Wrocław, Poland.
10Wroclaw Research Centre EIT+, Biobank, Wrocław, Poland.
 
 
In Poland storage of human biological samples takes place at most universities and scientific institutions conducting research projects in the field of biomedicine. The First International Biobanking Conference organized by the Ministry of Science and Higher Education in 2014 shed a light on the situation of Polish biobanking infrastructures. The country has around 40 large biorepositories, which store unique biological material such as whole brains, muscle fibers from patients with rare diseases, as well as thousands of samples from patients with lifestyle diseases. There are only two population-based biobanks working locally and several disease-oriented biobanks specializing mainly in oncological diseases. Consortium BBMRI.pl created plans for establishing a Polish Network of Biobanks, with national node which meets standards for biobanks and cooperation to guarantee development of biomedical sciences and international collaboration between Poland and other countries. The Polish network will enhance research activities, due to better visibility of samples and data that are stored in the national biobanking catalogue. However, it requires more than a comprehensive understanding of all benefits. The list of examples of benefits can be presented as follows: (i) a reduction of the duration and cost of clinical trials and subsequent time to market for anticancer drugs; (ii) more precise patient diagnosis and the associated impact on treatment and lower healthcare costs for providers, individuals, and the nation; (iii) improvements in research experiment time frames and data efficiencies; (iv) convergence to an industry standards for biospecimen quality; (v) optimization of capital infrastructure and IT technology.